Development of Targeted DNA-damaging Therapy for ATRX-deficient Pediatric Glioblastoma |
University of Michigan / Carl Koschmann, MD |
Young Investigator Grants |
2014 |
Michigan |
Identification of FDA approved drugs with anti-tumor activity in rhabdomyosarcoma.
|
Massachusetts General Hospital / David Langenau |
Young Investigator Grants |
2009 |
Massachusetts |
Immunotherapeutic Targeting of Stem Cells in Pediatric Brain Tumors
|
Harbor - UCLA Medical Center / Joseph Lasky |
Young Investigator Grants |
2008 |
California |
Identification of Novel Treatment Targets by Exploring the Interaction of Rhabdomyosarcoma-Associated Oncogenes with Cellular Context in a Mouse Model of Rhabdomyosarcoma |
Dana-Farber Cancer Institute / Simone Hettmer |
Young Investigator Grants |
2010 |
Massachusetts |
Histone Modification and Hmgn1 Overexpression as Drivers of B-ALL with Polysomy 21 |
Dana-Farber Cancer Institute / Andrew Lane, MD, PhD |
Young Investigator Grants |
2013 |
Massachusetts |
End-of-Life Care of Children with Cancer: Variation and Stakeholder Priorities |
University of Alabama at Birmingham / Emily Johnston, MD |
Young Investigator Grants |
2017 |
Alabama |
Targeting the Metabolic Drivers of Chemo Resistance in Acute Myeloid Leukemia |
Harvard University / Nick van Gastel, PhD |
Young Investigator Grants |
2018 |
Massachusetts |
Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2 |
Baylor College of Medicine / Andras Heczey, MD |
Young Investigator Grants |
2014 |
Texas |
Genetic Regulators of ER Stress-induced Apoptosis in Pediatric Malignancies
|
Dana-Farber Cancer Institute / Ujwal Pyati |
Young Investigator Grants |
2009 |
Massachusetts |
The TC3 Line, a Zebrafish Model of T-Cell Malignancy
|
Huntsman Cancer Institute / Nathan Meeker, MD |
Young Investigator Grants |
2008 |
Utah |